Author

Qikai Xu

Brigham and Women's HospitalORCID 0000-0003-0622-0998Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Behnam NabetiD· 1 shared Emma V. WatsoniD· 1 shared Mei Yuk Choi· 1 shared Nathanael S. GrayiD· 1 shared Stephen Joseph ElledgeiD· 1 shared Timothy D. MartiniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Behnam NabetORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologybioRxivPreprintMay 13, 2024

Proteasomal control of anti-CRISPRs for the regulation of CRISPR/Cas9 activity using Cas9-ACROBAT

Timothy D. Martin, Emma V. Watson, Mei Yuk Choi…·Stephen Joseph Elledge

The paper describes a method to control CRISPR/Cas9 activity using proteasomal degradation of an anti-CRISPR protein fused to a degradation or shutoff tag.

DOI 10.1101/2024.05.13.593596

CRISPR screenexperimental assay

𝕏 PostBluesky